Contact inhibition adjusts organ size to the proper size and ensures the cultured cells growing to a monolayer. By regulating the downstream coordinator YAP, the evolutionarily conserved Hippo transduction pathway attunes cell growth and death in response to cell contact inhibition, polarity, self-renewal, and differentiation. Dysregulation of this pathway is involved in various diseases such as cancer. RNA-binding protein QKI regulates cell proliferation, metabolism, division, and immunity in various cancer models, but its role in cancer cell contact inhibition remains unclear. In this study, we aimed to clarify the relationship between QKI and YAP, and the role of their interaction in cell contact inhibition. We found a lower QKI expression level in sparse condition, whereas a higher expression level in confluent condition by western blot analysis and immunofluorescence assay. QKI knockdown elevated cell proliferation and invasion both in vitro and in vivo. Strikingly, the results of CCK-8 assay, colony formation assay, and transwell assay showed that the phenomenon was in accord with the expression level of pYAP and reverse with YAP. Higher levels of Wnt3a and β-catenin were also found in xenografts of QKI-knockdown clear cell renal cell carcinoma (ccRCC) CAKI-1 cells by western blot analysis and immumohistochemical staining. Finally, a positive correlation between QKI and pYAP was found in clinical specimens by immunohistochemistry. Thus, as a negative regulator of YAP, QKI attuned the cell contact inhibition, leading to inhibition of cancer cell proliferation and invasion through Wnt and GPCR pathway.
Introduction
Although the targeted therapies have been improved, clear cell renal cell carcinoma (ccRCC) remains the most common kidney cancer in the world, ranking the top 10 in morbidity and mortality [1] . Cell contact inhibition plays a key role in suppressing the proliferation of normal cells when they are reaching confluence, which maintains the tissue homeostasis and organ size [2] . The majority of malignant tumor cells are refractory to the confluence-induced proliferation arrest and display anchorage-independent growth in suspension [3] . The progression of ccRCC is closely related to the uncontrolled cell contact inhibition [4] which ultimately leads to the malignant proliferation and increased invasiveness, suggesting a clinical need to explore the mechanism of how cell contact inhibition is regulated, which might provide new therapeutic targets or new treatment methods for ccRCC.
The Hippo cascade pathway, initially discovered as a suppressor of tissue over growth in Drosophila [5] , plays a crucial role in regulating organ size via controlling cell proliferation and apoptosis [6] . Moreover, Hippo pathway is the major regulatory mechanism of cell contact inhibition that is deregulated during carcinogenesis [7, 8] . Deregulation of this pathway has been shown to engage in tumor initiation and progression. As a negatively-regulated downstream modulator of the Hippo cascade pathway, Yes-associated protein (YAP) is implicated in regulation of cell proliferation, differentiation, and tissue regeneration [9, 10] . Inhibition of the Hippo pathway would promote the nuclear translocation of YAP, and subsequently trigger the expression of proliferative genes, while phosphorylation by activated Lats1/2-Mob1 complex on specific serine residue (Ser127) of YAP confines it in the cytoplasm for degradation [11] . Chen et al. [12] found that ccRCC progression was associated with lower LATS1 content and decreased LATS1 mRNA and protein levels were observed in tumor samples. In addition, REGγ was reported to modulate Hippo signaling pathway in a CK1ε-dependent manner in RCC [13] . Angiomotin (AMOT) has been reported to prevent the nuclear translocation of YAP by binding with the WW domain of YAP [14] . A large number of studies suggest that YAP functions prominently in cancer development including tumor initiation, progression, and metastasis [15] [16] [17] . Levels of YAP expression or activation showed its association with disease outcome [18] . Furthermore, upregulation of YAP has been found in various cancers, suggesting that it may be a novel therapeutic target. Therefore, it is important to explore alternative regulatory mechanisms of YAP in ccRCC.
Quaking (QKI) belongs to the conserved signal transduction and activator of RNA (STAR) family, as well as an hnRNP KH (K homology)-type family. Through binding with the bipartite consensus sequence ACUAAY[N1-20]UAAY, also known as QKI response element (QRE), in the 3′-UTR of the target mRNAs [19] , QKI regulates mRNA stability, RNA transportation, translation, circular RNA biogenesis, and miRNA processing [20] [21] [22] . Recent studies have also suggested a tumor suppressor role of QKI, as its reduced expression was found in numerous types of cancer such as glioma [23] , colon cancer [24] , prostate cancer [25] , and gastric cancer [26, 27] .
In this study, we sought to verify the impact of QKI on cell contact inhibition and clarify the role of QKI in ccRCC cells. We found a positive correlation between cell density and QKI expression level. Knockdown of QKI reduces the effect of cell contact inhibition, thereby promotes proliferation and metastasis of ccRCC cells in vitro and in vivo. Such effects may result from disturbance of YAP activation by QKI during cell confluences via Wnt and GPCR pathway in ccRCC cells.
Materials and Methods

Patients
Tumor and parallel adjacent tissues samples of 50 ccRCC patients (clinical information of patients was shown in Supplementary  Table S1 ) after surgery were obtained from Xijing Hospital in 2018.
Written informed consent was obtained from all subjects prior to the study. This study was approved by the Research Ethics Committee of Xijing Hospital.
Cell culture and reagents
Human renal cancer cell line CAKI-1, human hepatoma carcinoma cell line HepG2, and colorectal cancer cell line SW620 were purchased from American Tissue Culture Collection (Manassas, USA). CAKI-1 cells were routinely cultured in the MycCoy's 5A medium (Invitrogen-Gibco, Carlsbad, USA), HepG2 cells were maintained in Dulbecco's modified Eagle's medium (Invitrogen-Gibco), and SW620 cells were cultured in RPMI 1640 medium (Invitrogen-Gibco). The medium was supplemented with 10% (v/v) fetal bovine serum (Gibco, Grand Island, USA), 100 U/ml penicillin and 100 μg/ml streptomycin (Sigma-Aldrich, St Louis, USA). Cells were maintained at 37°C in a humidified atmosphere with 5% CO 2 . For immunofluorescence detection under sparse culture conditions, 1 × 10 4 cells were seeded in confocal dishes and allowed to spread overnight. For confluent assays, 5 × 10 4 cells were plated and cultured. YAP inhibitor Verteporfin, Wnt inhibitor C59, and RhoA inhibitor CCG-1423 were purchased from Selleck (Shanghai, China).
QKI silencing or restoration by lentivirus
The QKI interfering or overexpression lentiviruses were generated as previously reported [22] . Briefly, cells were seeded in 6-well plates to reach the adherent confluence at 60%-70% at the time of infection. Then, 8 μg/ml polybrene (Santa Cruz Biotech, Santa Cruz, USA) was added with the lentiviral particles to enhance the infection efficiency. Stable CAKI-1 and HepG2 cell lines that carrying scramble sequence (Scr) or siQKI (Q4) were selected with puromycin (Invitrogen, Carlsbad, USA) at a final concentration of 4 μg/ml, and 2 μg/ml blasticidine (Invitrogen) was added to the medium to select QKI overexpression (Q5) SW620 cells or QKI restoration in CAKI-Q4 and HepG2-Q4 cells which were marked as CAKI-Res and HepG2-Res, respectively. QKI-Scr: sense, 5′-CAGGTACTGAAGAACAATCTTTGdTdT-3′, anti-sense, 5′-CAAGATTGTTGTCTTCAGTACCTdTdT-3′; QKI-Q4: sense, 5′-GAACAAAGAAACCCUUUAUdTdT-3′, anti-sense, 5′-AUAAAGGGUUUCUUUGUUCdTdT-3′.
Immunofluorescence analysis
Cells were washed with PBS for three times and then fixed in 4% para-formaldehyde for 10 min at room temperature. Cells were then treated with permeabilization solution (1% Triton X-100 in PBS) for 10 min, and subsequently blocked with 1% BSA for 30 min at room temperature. Samples were then incubated with anti-QKI antibody (1:500; Sigma-Aldrich) or anti-YAP antibody (1:500; Cell Signaling Technology, St Louis, USA) overnight at 4°C. Cells were then washed with PBS for three times, followed by incubation with anti-rabbit IgG antibody (1:200; Cell Signaling Technology) for 2 h. Nuclear staining was conducted using DAPI (1:1000; SigmaAldrich). Representative images were examined by laser scanning confocal microscopy (A1R; Nikon, Tokyo, Japan).
Western blot analysis
Total protein was extracted from cells using RIPA lysis buffer (Cell Signaling Technology) and protein concentration was determined by using BCA Protein Assay kit (Thermo Fisher, Waltham, USA). Briefly, 30 μg of protein was subject to 10% SDS-PAGE and electrotransferred to nitrocellulose (NC) membranes. Membranes were blocked with 5% non-fat milk and then incubated with primary antibodies against YAP, pYAP, LaminA/C, LRP5/6, Wnt3a, RhoA, β-catenin, TCF1/7, c-Myc (1:1000; Cell Signaling Technology), QKI (1:1000; Sigma-Aldrich), and β-actin (1:1000; Sangon, Shanghai, China) at 4°C overnight. After three times of wash with TBST, membranes were incubated with the appropriate HRP-conjugated secondary antibodies (1:5000; Kangwei, Shanghai, China) for 1 h. Signals were visualized with an enhanced chemiluminescence western blot detection kit (Pierce Biotechnology, Rockford, USA). The band intensity was quantified by densitometry and normalized to β-actin using Image J analysis software.
Quantitative real-time PCR
Trizol Reagent (Invitrogen) was used to extract total RNA. Subsequently, cDNA was generated by using Primescript first strand cDNA synthesis Kit (Takara, Shiga, Japan). Quantitative real-time PCR was carried out by using SYBR Premix Ex Taq (Takara), with β-actin as the endogenous control. All reactions were performed on the ABI Prism 7500 Detection System (ABI, Carlsbad, USA) with at least triplicates prepared for each sample. The sequences of primers used in qRT-PCR are shown as follows: QKI: forward, 5′-TAGCAGAGTACGGAAAGACATG-3′, reverse, 5′-GGGTATTC TTTTACAGGCACAT-3′; CTGF: forward, 5′-CAGCATGGAC GTTCGTCTG-3′, reverse, 5′-AACCACGGT TTGGTCCTTGG-3′; CYR61: forward, 5′-GGTCAAAGTTACCGGGCAGT-3′, reverse, 5′-GGAGGCATCGAATCCCAGC-3′; β-actin: forward, 5′-AGA GGGAAATCGTGCGTGAC-3′, reverse, 5′-TTCTCCAGGGAGG AAGAGGAT-3′. Transcriptional expression of target genes was calculated using the 2 −ΔΔCt method.
Colony formation assay
About 400 viable infected CAKI-1 cells were seeded into 6-cm dishes and maintained in MycCoy's 5A medium for 10-14 days. Then, the cells were fixed with methanol and stained with 0.5% crystal violet. The number of colonies was scored with the representative photograph using a microscope (Olympus, Tokyo, Japan).
CCK-8 assay
CCK-8 assay for cell proliferation was performed according to the manufacturer's instruction (Dojindo, Kumamoto, Japan). Briefly, cells were seeded into 96-well plates in sextuple at number of 1000/ 3000/5000 cells per well and incubated under normal conditions for 24 h. Subsequently, 10 μl of CCK-8 was added into each well of the plate and then incubated for additional 1 h at 37°C. The OD values were detected using a microplate reader (Bio-Rad, Hercules, USA) at 450 nm. For the anchorage-independent viability assay, 3000 cells were suspended in MycCoy's 5A medium containing 10% FCS and 0.2% low melting agarose (Invitrogen, Carlsbad, USA) and seeded in sextuple at 500 cells/well in 96-well plates which were precoated with 1.5 mg/ml Collagen I and (1:8 diluted) matrigel (BD Biosciences, Bedford, USA). About 50 μl of complete medium was added to each well every 3 days to prevent desiccation. Number of colonies in each well was recorded after one week. Cell viability was defined as the ratio of the colony numbers to Q4 group.
In vivo xenograft and pulmonary metastasis model
In brief, 4-6-week-old BALB/c nude mice were purchased from the Forth Military Medical University Experimental Center and maintained under specific pathogen-free conditions. The animal study was approved by the Institutional Animal Ethics Committee of the Forth Military Medical University. For xenograft tumor formation, 1 × 10 7 infected (CAKI-Scr, CAKI-Q4, or CAKI-Res) cells suspended in 200 μl PBS were subcutaneously injected into nude mice. Tumor volume was measured every 3 days since the tumors got visible and calculated using the formula:
where v is volume, L is length, and W is width. At the end of experiment, mice were euthanized and the tumors were weighed and dissected for immunostaining analysis. For pulmonary metastasis detections, nude mice were injected intravenously with 5 × 10 6 infected (CAKI-Scr or CAKI-Q4) cells through the tail vein. Seven weeks after injection, the lungs were isolated and embedded in paraffin. The lung metastases were quantified under the microscope after hematoxylin and eosin (H&E) staining.
Transwell assay
Cell migration was detected by using transwell chambers (8-μm pore size; BD Pharmingen, San Diego, USA). In brief, 5 × 10 3 viable infected CAKI-1 cells were suspended in 150 μl FBS-free medium and seeded in the upper chamber, which are inserted in 24-well tissue culture plates containing 10% FBS medium. After 24 h, migrated cells was stained with Giemsa and analyzed with the microscope. The experiments were repeated three times.
Immunohistochemistry ccRCC xenograft specimens were fixed in 4% para-formaldehyde, dehydrated and embedded in paraffin, and stained with H&E according to the routine protocols. Immunostaining was performed using the primary antibodies against Wnt3a, β-catenin, YAP, and pYAP (Cell Signaling Technology). Staining procedures were conducted according to the manufacturer's instructions.
Tissue microarray analysis
To detect the expression of QKI and pYAP in clinical samples, immunohistochemistry was performed in microarray of tumors and their adjacent tissues of 50 patients (Supplementary Table S1 ). Green/red fluorescent monochromatic images were converted into black-white ones by Image-Pro Plus 6.0. The integrated optic density (IOD) was calculated, by setting the black background as positive criteria. Outliers (IOD-QKI, IOD-pYAP greater than 5000) were removed from our records according to practical significance. Column-wised normalization was used to eliminate the impact of variables' scale, i.e. the mean was subtracted from each variable of QKI and pYAP, and then standard deviation (SD) was divided. Regression model pre-specification and estimation, hypothesis tests were employed to detect the outliers of IOD-QKI, IOD-pYAP, and the observations were deleted if they were outliers in the sense of statistical significance by carrying out Bonferroni test no more than three times. Reconstruction of regression model was established to measure the correlations of variables.
Statistical analysis
Data are expressed as the mean ± SD and statistical analyses were performed with SPSS 16.0 software (SPSS, Chicago, USA). One-way analysis of variance (ANOVA) was used and significant differences between two groups were compared using the Student's t-test. P <0.05 was considered to be statistically significant.
Results
QKI and YAP expression profiles in different cell densities
To elucidate whether QKI expression is related to cell contact inhibition in different cell densities, we examined the expression of QKI in CAKI-1 cells at density of 1 × 10 4 cells/well (sparse state) and 5 × 10 4 cells/well (confluent state). A higher QKI expression level was detected in confluent culture condition, while the expression of QKI was low in sparse condition (Fig. 1A,C) . As a negatively-regulated downstream modulator of the Hippo cascade pathway, YAP is implicated in regulation of cell contact inhibition. We then detected YAP activation status in different cell densities. As shown in Fig. 1B ,C, phosphorylated YAP was increased but YAP expression was reduced in confluent condition compared with those in the sparse condition. Therefore, QKI may play a novel role in different cell densities via adjusting YAP activation status.
QKI negatively regulates YAP activation
To investigate how QKI influences the activation of YAP, QKI silencing (Q4), QKI restoration (Res), and the control (Scr) CAKI-1 cells were established by using lentivirus infection ( Fig. 2A,B , P < 0.05 for Q4 vs. Scr; P < 0.05 for Res vs. Q4). As expected, YAP was mainly expressed in the nuclei in QKI-silenced group (Q4) as well as in control (Scr) in sparse state (Fig. 2C) ; while in confluent state, the expression of YAP and its nuclear translocation were remarkably elevated in QKI-silenced cells ( Fig. 2A,D and Supplementary  Fig. S1 ). Increased mRNA levels of YAP target genes CTGF and CYR61 were also found in QKI-silenced CAKI-1 cells ( Supplementary   Fig. S1 ). These data indicated that YAP was negatively regulated by QKI.
QKI inhibits cell proliferation partially via YAP regulation in CAKI-1 cells
Cell contact inhibition plays a key role in suppressing cell proliferation when cells reach confluence. To elucidate the effect of QKI on cell proliferation in different cell density conditions, we detected cell viability by using CCK-8 kit. As shown in Fig. 3A , QKI silencing led to a markedly increased cell viability in confluent conditions, while restoration of QKI led to an opposite result (P < 0.05 for Q4 vs. Scr; P < 0.05 for Res vs. Q4). Therefore, knockdown of QKI reduced the effect of cell contact inhibition and promoted cell growth. As expected, colony formation assay ( Fig. 3B , P < 0.05 for Scr, Res vs. Q4) and anchorage-independent viability assay ( Fig. 3C , P < 0.05 for Q4 vs. Scr; P < 0.05 for Res vs. Q4) revealed that cell viability was increased upon QKI interfering. As shown in Fig. 3D , the viability of cells in each group was significantly decreased by YAP inhibitor, Verteporfin. The effect displayed dose-dependent and got aggravated in QKI-silenced group (P < 0.05 for 2, 4 μM vs. 0 μM). These data suggested that QKI inhibited YAP activation and subsequently inhibited cancer cell proliferation.
Effects of QKI silencing on tumor growth and metastasis in nude mice
To investigate the effect of QKI on tumor growth, 1 × and western blot analysis (C). The relative band intensity was quantified by densitometry and normalized to β-actin or LaminA/C using Image J analysis software. Each experiment was repeated three times and data are presented as the mean ± SD. *P < 0.05 for confluent vs. sparse.
were subcutaneously injected into nude mice. In vivo xenograft study showed that QKI silencing promoted tumor growth in nude mice (Fig. 4A-C , P < 0.001 for Scr, Res vs. Q4). Moreover, knockdown of QKI promoted lung metastases formation of CAKI-1 cells (Fig. 4D,E) . To prove the effect of QKI on CAKI-1 cell migration, transwell assay was performed. As shown in Fig. 4F , knockdown of QKI promoted cell migration, while restoration of QKI inhibited cell migration (P < 0.05 for Q4 vs. Scr; P < 0.05 for Res vs. Q4). These data suggested that QKI plays a key role in the regulation of proliferation and metastasis of ccRCC cells. QKI adjusts cell contact inhibition via the Wnt3a/β-catenin/TCF1/7/RhoA/YAP axis Since QKI plays an important role in regulating YAP and subsequently influencing cell contact inhibition, it is important to elucidate which pathway is involved in. Activation of Wnt signal could reduce the effect of cell contact inhibition or induce resistance to the contact inhibition. It is of interest to explore whether QKI modulates YAP activity via Wnt signal transduction pathway. Western blot analysis was performed to detect the expression status of Wnt signal molecules. QKI silencing promoted β-catenin nuclear translocation and thereby induced activation of TCF1/7 as seen in Fig. 5A and Supplementary Fig. S2 . . QKI adjusts cell contact inhibition via Wnt3a/β-catenin/TCF1/7/RhoA/YAP axis (A,B) Expressions of Wnt3a, β-catenin, TCF1/7, LRP6, and RhoA in control (Scr), QKI-knockdown (Q4) and QKI-restoration (Res) CAKI-1 cells were detected by western blot analysis. The relative protein band intensity was quantified by densitometry and normalized to β-actin using Image J analysis software. Each experiment was repeated three times and data are presented as the mean ± SD. *P < 0.05 for Q4 vs. Scr; # P < 0.05 for Res vs. Q4. (C,D) QKI-silenced CAKI-1 cells were cultured in medium with/without 100 mM C59 (Wnt inhibitor) or 1.5 μM CCG-1423 (RhoA inhibitor) for 24 h. Levels of YAP and pYAP expression were detected by western blot analysis. The relative protein band intensity was quantified by densitometry and normalized to β-actin using Image J analysis software. Each experiment was repeated three times and data are presented as the mean ± SD. *P < 0.05 for inhibitor− vs. inhibitor+. (E) Immunohistochemistry staining showing consistent expressions of Wnt3a, β-catenin, pYAP, and YAP in the xenografts of CAKI-Scr and CAKI-Q4.
LRP6 were decreased when QKI expression was restored or QKI was overexpressed (Fig. 5A,B and Supplementary Fig. S2 ). Wnt signal was reported to interact with G protein coupled receptor (GPCR) to regulate the activity of YAP via RhoA. Hence, we examined the expression level of RhoA in the above cells. RhoA was significantly upregulated in QKI-silenced cells but downregulated when QKI expression was restored (Fig. 5B) . Furthermore, QKI overexpression significantly decreased RhoA expression in SW620 cells ( Supplementary Fig. S2 ). Reduced YAP expression and increased pYAP were also observed upon Wnt inhibitor (C59) or RhoA inhibitor (CCG-1423) treatment in QKI-silenced cells (Fig. 5C,D) . Consistently, Wnt3a and YAP were increased in QKI silencing (Q4) xenografts (Fig. 5E ). These data indicated that QKI could modulate cell contact inhibition via Wnt3a/β-catenin/TCF1/7/RhoA/YAP axis.
QKI expression is positively correlated with pYAP expression in clinical tissue samples
Nuclear translocation of YAP triggers the expression of proliferative genes, while phosphorylation of YAP confines it in the cytoplasm for degradation. Immunohistochemistry was performed to detect the expressions of QKI and pYAP in patient tissue microarray (Fig. 6A) .
In cancer tissues, pYAP levels were positively correlated with QKI protein levels (Fig. 6A ,B, R 2 = 0.8562, P < 0.0001). There was no significant correlation between the QKI and pYAP in adjacent tissues (Fig. 6C , R 2 = 0.001306, P = 0.8551). As shown in Fig. 6D -F, pYAP levels were positively correlated with QKI levels in TNM I (R 2 = 0.7136, P < 0.0001) and TNM III-IV (R 2 = 0.9141, P = 0.0008). However, no significant correlation was found between QKI expression and pYAP in TNM II (Fig. 6E) . Then we detected the expression levels of QKI and pYAP in different stages of ccRCC. Both QKI and p-YAP expressions were significantly reduced in TNM II compared with that in TNM I and TNM III-IV (Fig. 6G ,H, P < 0.05). These data indicated that QKI was positively related with pYAP in clinical tissue samples.
Discussion
In the present study, we firstly demonstrated a tumor suppressor role of QKI in ccRCC through modulating cell contact inhibition via Wnt3a/β-catenin/TCF1/7/RhoA/YAP axis. Cell contact inhibition plays an important role in tissue growth control. At cellular level, it occurs as cells reach a high density. Contact inhibition ensures the cells stop growing when they grow to fusion. In contrast, most cancer cells exhibit contact inhibition resistance. Hanahan and Weinberg pointed out that loss of contact inhibition regulation and obtain anchorage-independent proliferation ability to resist apoptosis is one of the remarkable characteristics of tumor cells [28] . Earlier studies about QKI mainly focused on the nervous system. Reduction of QKI 6 and QKI 7 in mice models may lead to myelination defect [29] . Complete knockout of QKI will result in embryonic lethality because of the neural tube mature disorder and defective angiogenesis [30] . In recent years, more and more studies revealed that QKI is involved in embryogenesis, angiogenesis, glial differentiation, apoptosis, and transcription [31] [32] [33] [34] [35] . QKI acts as a tumor suppressor in gastric cancer, prostate cancer and colon cancer [23] [24] [25] [26] 34, 36] by targeting Ras, Jun, Fos, β-catenin, p27, and p53 [37] . Studies about QKI and renal cancer were limited. One report showed that reduction of QKI 5 was related to clinical TM stages, [38] . In the present study, we found that QKI-silenced CAKI-1 cells could continue to proliferate when cells reached confluence and contacted with each other, while the control and QKI-restoration groups showed decreased proliferation capacity. This suggests that knockdown of QKI may result in a decrease or absence of cell contact inhibition, and QKI may be involved in regulating cell contact inhibition. Therefore, we hypothesized that QKI may participate in the regulation of cell contact inhibition-mediated density-dependent cell proliferation. Consistently, knockdown of QKI promoted CAKI-1 xenograft growth in vivo, which claimed the tumor suppressor role of QKI.
CAKI-Q4 CAKI-Scr
The Hippo signal transduction pathway is one of the most important pathways that regulate cell proliferation and contact inhibition. Recent studies showed that there is little or no contact between the cells or between the cells and the basal surface when cells are in a low-density state. Consistent with previous studies, we found that YAP could be rapidly phosphorylated and transferred from the nucleus to the cytoplasm when cell number increased. This suggests that the activity and location of YAP are regulated by cell density or cell contact inhibition. Moreover, the expressions of YAP and pYAP are closely related to QKI, as well as cell density.
The Wnt signaling pathway was firstly reported by Nusse and Varmus in 1982 [39] . Wnt signaling pathways was reported to be coupled with multiple signal transduction pathways, including Notch-Delta pathway, Hedgehog pathway, transforming growth factor beta (TGF-β), and Hippo signal transduction pathways [40] . Wnt signaling pathway regulates cell behavior in two main ways: the classical Wnt signal transduction pathway which mainly relies on regulating the activity of β-catenin, and the non-classical Wnt signaling pathway which does not rely on the activity of β-catenin. Effect of Wnt depends on the Wnt ligands on the cell membrane, including frizzled family (FZD), G protein coupled receptor (GPCRs), and tyrosine kinase receptor (RTKs). Wnt signals contain multiple subtypes with different functions. Wnt3a, WNT7a, and WNT1 regulate cellular biological behavior of epithelial cells, while WNT6, WNT4, and WNT5a do not [41, 42] . Wnt3a could promote cell proliferation via enhancing the stability of β-catenin and activity of TCF in bone tumors and urological tumors [43, 44] . A recent study showed that Wnt could activate YAP/TAZ [45] through Frizzled, G α12/13, Rho protein kinase and LATS1/2. We found that classical Wnt signaling pathways was activated after QKI intervention, thus affecting the activity of downstream RhoA which can promote cell proliferation by upregulating the activity of YAP and resistance contact inhibition.
Finally, we verified the relationship between QKI and pYAP expression in patient tissue samples. The results showed that the expression of QKI at different stages as well as total QKI expression was significantly positively correlated with pYAP, suggesting that QKI is also clinically related to the development of tumor.
In conclusion, we identified the relationship between QKI and cell contact inhibition. The regulatory effect of QKI on the key protein YAP in the Hippo signal transduction pathway was also identified. Meanwhile, this study preliminarily confirmed the underlying mechanism by which cell contact inhibition is adjusted. This provides new evidence for the regulation of cell proliferation by QKI and a new idea for the clinical application of RNA-binding protein QKI.
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